Sandoz remains committed to accelerating patient access by strengthening its biosimilar portfolio, reinforcing global and European leadership ...
Dupixent has been approved for CSU in Japan and the United Arab Emirates (UAE) and is also under regulatory review in the EU based on earlier study readouts. Outside of Japan and the UAE, the safety ...
Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activity M ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback